Fig. 2From: Oral chondroitin sulfate and prebiotics for the treatment of canine Inflammatory Bowel Disease: a randomized, controlled clinical trialOne-way ANOVA CIBDAI scores in group A (placebo) and B (supplement) 15 days before treatment start (1), and at 30 (2), 60 (3), 90 (4), 120 (5) and 180 (6) days of treatment. Asterisks indicate statistical significance compared to pretreatment values (*p < 0.05; **p < 0.01; ***p < 0.001; ****p < 0.0001)Back to article page